Founded with a mission to address dermatological conditions caused by sun exposure, Biofrontera Inc. is a biopharmaceutical company focused on the U.S. market. The company specializes in the commercialization of innovative therapies, particularly in photodynamic therapy and topical antibiotics. Biofrontera aims to improve patient outcomes through advanced nanoemulsion technology, which enhances the stability and penetration of active ingredients in their formulations.
Biofrontera has garnered attention for its impactful products in the dermatology community, leveraging cutting-edge technology to meet patient needs effectively. The company's achievements include the successful commercialization of its treatment options, which have been well-received by healthcare providers and patients alike. Biofrontera continues to make significant strides in the field of dermatology, contributing to better skin health and quality of life for individuals affected by sun-induced skin damage.
